a negative trendP = 0.08
( 2020 ) found that exposure to NSAIDs (−365 to −14 days prior to baseline) was modestly associated with increased likelihood of COVID‐19 infection (multivariable odds ratio [OR] 1.27, 95% confidence interval [CI] 1.02–1.58), was not associated with hospitalisation ( P = 0.19), and had a negative trend of association with intensive care ( P = 0.08).